Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rosengarten & Sons was a prominent 19th-century American chemical manufacturing company based in Philadelphia, Pennsylvania. Founded in the early 1820s, the firm became a leading producer of medicinal chemicals, most notably quinine and morphine. In 1905, the company merged with its rival, Powers & Weightman, to form the Powers-Weightman-Rosengarten Company. This entity was eventually acquired by Merck & Co. in 1927, making Rosengarten & Sons a foundational ancestor of the modern Merck. The company played a critical role in the development of the American pharmaceutical industry by providing high-quality standardized chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rosengarten and Sons.